Freiburg, Germany

Daniel Kühne

This inventor holds 3 USPTO granted patents. Top assignees: Stryker European Operations Limited, Mako Surgical Corporation. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Daniel Kühne. Retrieved from https://idiyas.com/inventor/daniel-kühne

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Daniel Kühne

Introduction

Daniel Kühne is a notable inventor based in Freiburg, Germany. He has made significant contributions to the field of surgical instruments, holding a total of 3 patents. His work is primarily associated with Stryker European Operations Limited, a company renowned for its medical technology innovations.

Latest Patents

Kühne's latest patents include a surgical instrument and a surgical tracker. These inventions reflect his commitment to enhancing surgical procedures and improving patient outcomes.

Career Highlights

Throughout his career, Daniel Kühne has demonstrated a strong dedication to innovation in the medical field. His role at Stryker European Operations Limited has allowed him to work on cutting-edge technologies that are vital for modern healthcare.

Collaborations

Kühne has collaborated with talented individuals such as Kana Nishimura and Fabian Riegelsberger. These partnerships have contributed to the development of advanced medical solutions.

Conclusion

Daniel Kühne's contributions to surgical technology exemplify the impact of innovation in healthcare. His patents and collaborations continue to influence the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…